Therapeutic advances in non-small cell lung cancer with met exon 14 skipping alterations

11 Jan 2023Oncology

Coco Chong

This content is sponsored. It is intended for healthcare professionals only.

At a meeting held on 16th June, 2022, Professor Myung-Ju Ahn from the Department of Haematology and Oncology at Samsung Medical Centre, and Dr Jonathan Nyaw Shi Feng from the Department of Clinical Oncology at Tuen Mun Hospital, presented on the modern treatment for MET exon 14 skipping mutations (METex14+) in non-small cell lung cancer (NSCLC).

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.